SCHEMBL4366635

SCHEMBL4366635

COc1ccccc1C(NCC(O)COCc1cccc2ccccc12)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 2/20 0.46
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
CYP2D6 P10635 4/20 0.39
ADRB2 P07550 6/20 0.39
ADRB1 P08588 5/20 0.39
SIGMAR1 Q99720 4/20 0.39
ADRB3 P13945 4/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 3/20 0.39
SLC6A4 P31645 3/20 0.39
HTR2B P41595 3/20 0.39
NR2E1 Q9Y466 3/20 0.39
HTR2A P28223 3/20 0.39
HTR2C P28335 3/20 0.39
HTR6 P50406 3/20 0.39
TSHR P16473 3/20 0.39
SCN1A P35498 2/20 0.39
SLC10A1 Q14973 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4366631 1.00 CASR (0.46) CASRMEN1KMT2AL3MBTL1CYP2D6
SCHEMBL4366632 0.86 CASR (0.50) CASRMEN1KMT2AL3MBTL1ADRB2
SCHEMBL4374348 0.80 MAPT (0.48) CASRMEN1KMT2ACYP2D6ADRB2
SCHEMBL4374354 0.80 MAPT (0.48) CASRMEN1KMT2ACYP2D6ADRB2
SCHEMBL4367360 0.74 KMT2A (0.38) MEN1KMT2AADRB2ALDH1A1SMN1; SMN2
SCHEMBL4367354 0.74 KMT2A (0.38) MEN1KMT2AADRB2ALDH1A1SMN1; SMN2
SCHEMBL21792805 0.72 ADRB2 (0.64) CASRCYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL4367349 0.69 MEN1 (0.58) CASRMEN1KMT2ACYP1A2NR2E1
SCHEMBL4362996 0.68 ALDH1A1 (0.42) MEN1KMT2AL3MBTL1ALDH1A1TSHR
SCHEMBL2490295 0.67 KCNN4 (0.61) MEN1KMT2AL3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1908829-B1 OLIGONUCLEOTIDE PROBE NAT INST OF ADVANCED IND SCIEN (JP) 2014-01-08 EP disclosed
US-7491857-B2 Oligonucleotide probe NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2009-02-17 US disclosed
US-20080227968-A1 Oligonucleotide Probe NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-18 US disclosed
EP-1908829-A1 OLIGONUCLEOTIDE PROBE National Institute of Advanced Industrial Science and Technology (JP) 2008-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227968-A1 Oligonucleotide Probe APEX1, RNGTT, RNASEH1 CASR 2347/4885MEN1 1946/4885KMT2A 3173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.